Donald Crabtree, DO
Pain Medicine · Hot Springs, ARNPI 1760649388
Payments from drug & device makers
What this record shows
Edwards Lifesciences accounts for 61.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $2,023 and has fallen 93.5% since, to $131 in 2025. That places this record below the midpoint for pain medicine clinicians in AR, where the typical reported total is $3,271.
Across 59 payments — averaging $55.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$2K
- Boston Scientific$459
- AbbVie$319
- Collegium Pharmaceutical, Inc.$151
- Phathom Pharmaceuticals, Inc.$125
- Globus Medical$60
- plus $152 from 6 others
What the payments were for
- Travel & lodging$1,65651%
- Food & beverage$1,61549%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 11 | $2,006 |
| Boston Scientific | 13 | $459 |
| AbbVie(2 entities) | 13 | $319 |
| Collegium Pharmaceutical, Inc. | 9 | $151 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Globus Medical | 3 | $60 |
| Biodelivery Sciences International, Inc. | 3 | $41 |
| Nevro Corp. | 2 | $38 |
| Redhill Biopharma Inc. | 1 | $25 |
| Abbott | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Zyla Life Sciences, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOQUEZNA$125
- GENERAL PAIN MANAGEMENT$112
- UBRELVY$109
- QULIPTA$109
How this compares
$3,271 in reported general payments places this provider in the 50th percentile of 53 pain medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,276 | $33,147 |
| Xtampza ErOxycodone Myristate | 38 | $20,980 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 584 | $15,598 |
| Hysingla ErHydrocodone Bitartrate | 14 | $12,844 |
| BelbucaBuprenorphine Hcl | 13 | $10,799 |
| Butorphanol Tartrate | 23 | $9,349 |
| Morphine Sulfate ErMorphine Sulfate | 160 | $4,971 |
| Naloxone Hcl | 45 | $3,203 |
| Oxycodone Hcl | 162 | $3,016 |
| Pregabalin | 138 | $2,345 |
| Gabapentin | 128 | $2,231 |
| Buprenorphine Hcl | 25 | $1,687 |
| Fentanyl | 26 | $1,642 |
| Morphine Sulfate | 58 | $1,412 |
| Tizanidine Hcl | 97 | $1,135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $151 | $31,77851 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 53 pain medicine providers in Arkansas.
Other pain medicine in Hot Springs
- Jacob AbrahamHot Springs$3K
- Stephen PaulusLittle Rock$75K
- Mark MiedemaFayetteville$35K
- George ArcosConway$30K
- George DeimelFayetteville$26K
- Julio OlayaLittle Rock$22K
- Maria Lyuksyutova-PriceMountain Home$19K
- Daniel JudkinsConway$17K
- Sheffield KentConway$16K
- Christopher MocekLittle Rock$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.